---
schema_version: "secwatch.filing_event.v1"
accession: "0001065949-22-000066"
form_type: "8-K"
ticker: "LIMX"
cik: "0001803977"
company_name: "Limitless X Holdings Inc."
filed_at: "2022-05-13T23:59:59+00:00"
generated_at: "2026-06-25T16:58:22.565475+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Bio Lab Naturals to acquire Limitless X in reverse merger; LXI shareholders to own ~90% of combined entity

## Summary
- Bio Lab Naturals will acquire all of Limitless X (health/wellness, beauty, CBD) via share exchange.
- LXI shareholders receive 97M BLAB common shares (plus 9M shares in 6 months), owning ~90% of combined company.
- LXI CEO to purchase 500K shares of BLAB Series A Preferred Stock with super voting rights (60% votes), effecting change in control.
- Closing targeted for May 20, 2022; transaction subject to customary conditions.

## SEC filing metadata
- accession: 0001065949-22-000066
- form_type: 8-K
- ticker: LIMX
- cik: 0001803977
- company_name: Limitless X Holdings Inc.
- filed_at: 2022-05-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 3.02, 5.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1803977/000106594922000066/0001065949-22-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1803977/000106594922000066/blab8kmay132022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001065949-22-000066
- JSON: https://secwatch.observer/filing/0001065949-22-000066.json
- Plain text: https://secwatch.observer/filing/0001065949-22-000066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.